Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Bavarian Nordic

181.55 DKK

+2.20 %

Less than 1K followers

BAVA

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Bavarian Nordic

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue1,363.42,093.95,716.21,346.61,651.51,794.91,451.06,244.0
EBITDA250.5911.31,603.1419.5541.81,325.5255.12,541.9
EBIT93.6709.2939.8258.9371.01,154.619.41,803.8
EBIT-%6.9 %33.9 %16.4 %19.2 %22.5 %64.3 %1.3 %28.9 %
Profit before taxes72.5747.1971.4229.5373.41,169.928.21,801.0
Net income70.5770.8988.0218.8362.61,092.8-298.81,375.4
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.